학술논문

Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease
Document Type
Journal
Source
NPJ PARKINSONS DISEASE; MAR 14 2024, 10 1, p60 2p.
Subject
Language
English
ISSN
23738057